Skip to main content
. Author manuscript; available in PMC: 2011 Nov 28.
Published in final edited form as: Anticancer Drugs. 2009 Mar;20(3):179–184. doi: 10.1097/CAD.0b013e328325a867

Table 1.

Patient Characteristics

Number of patients 28
Age in years, median (range) 67 (50–84)
Race/Ethnicity (%)
Caucasian 26 (93%)
Black 2 (7%)
Performance Status (%)
0 16 (57%)
1 8 (29%)
2 4 (14%)
Prior docetaxel-based therapy (%)
 Yes 9 (32%)
 No 19 (68%)